Guo, Jingchuan

Newer glucose‐lowering drugs and risk of dementia: A systematic review and meta‐analysis of observational studies

Tang, H., Shao, H., Shaaban, C. E., Yang, K., Brown, J., Anton, S., Wu, Y., Bress, A., Donahoo, W. T., DeKosky, S. T., et al. (2023) · Journal of the American Geriatrics Society

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 106

A scoping review of fair machine learning techniques when using real-world data

Huang, Y., Guo, J., Chen, W.-H., Lin, H.-Y., Tang, H., Wang, F., Xu, H., & Bian, J. (2024) · Journal of Biomedical Informatics

Ethics and Social Impacts of AIArtificial Intelligence in Healthcare and Education

Cited by 61

A Prescription for Achieving Equitable Access to Antiobesity Medications

Wright, D. R., Guo, J., & Hernandez, I. (2023) · JAMA Health Forum

Pharmacology and Obesity TreatmentObesity and Health Practices

Cited by 42

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes: A Target Trial Emulation Study

Tang, H., Lu, Y., Donahoo, W. T., Shao, H., Shi, L., Fonseca, V. A., Guo, Y., Bian, J., & Guo, J. (2024) · Annals of Internal Medicine

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 40

Regional trends and disparities in newer GLP1 receptor agonist initiation among real‐world adult patients eligible for obesity treatment

Radwan, R. M., Lee, Y. A., Kotecha, P., Wright, D. R., Hernandez, I., Ramon, R., Donahoo, W. T., Chen, Y., Allen, J. M., Bian, J., et al. (2025) · Diabetes Obesity and Metabolism

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 24

Association between antidepressants and dementia risk in older adults with depression: a systematic review and meta-analysis

Wang, G. H.-M., Li, P., Wang, Y., Guo, J., Wilson, D. L., & Lo-Ciganic, W.-H. (2023) · Journal of Clinical Medicine

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 23

Optimal blood pressure thresholds for minimal coronary artery disease risk in type 1 diabetes

Guo, J., Brooks, M. M., Muldoon, M. F., Naimi, A. I., Orchard, T. J., & Costacou, T. (2019) · Diabetes Care

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 22

Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform

Hernandez, I., Wright, D. R., Guo, J., & Shrank, W. H. (2024) · Journal of General Internal Medicine

Pharmacology and Obesity TreatmentHealthcare Policy and Management

Cited by 18

Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes

Chen, W.-H., Li, Y., Yang, L., Allen, J. M., Shao, H., Donahoo, W. T., Billelo, L., Hu, X., Shenkman, E. A., Bian, J., et al. (2024) · PLOS ONE

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 17

Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data

Yang, L., Gabriel, N., Hernandez, I., Winterstein, A. G., & Guo, J. (2021) · Pharmacoepidemiology and Drug Safety

Diabetic Foot Ulcer Assessment and ManagementDiabetes Treatment and Management

Cited by 17

A Fair Individualized Polysocial Risk Score for Identifying Increased Social Risk in Type 2 Diabetes

Huang, Y., Guo, J., Donahoo, W. T., Lee, Y. A., Fan, Z., Lu, Y., Chen, W.-H., Tang, H., Bilello, L., Saguil, A. A., et al. (2024) · Nature Communications

Machine Learning in HealthcareArtificial Intelligence in Healthcare

Cited by 14

Socioeconomic factors play a more important role than clinical needs in the use of SGLT2 inhibitors and GLP-1 receptor agonists in people with type 2 diabetes.

Shao, H., Li, P., Guo, J., Fonseca, V., Shi, L., & Zhang, P. (2022) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 13

Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study

Wang, G. H.-M., Chen, W.-H., Chang, S.-H., Zhang, T., Shao, H., Guo, J., & Lo-Ciganic, W.-H. (2023) · BMC Geriatrics

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 13

Advancing social determinants of health research and practice: Data, tools, and implementation

Li, C., Guo, J., Bian, J., & Becich, M. J. (2025) · Journal of Clinical and Translational Science

Health disparities and outcomesPublic Health and Social Inequalities

Cited by 5

Identification of outcome-oriented progression subtypes from mild cognitive impairment to Alzheimer's disease using electronic health records

Xu, J., Yin, R., Huang, Y., Gao, H., Wu, Y., Guo, J., Smith, G. E., DeKosky, S. T., Wang, F., Guo, Y., et al. (2023) · medRxiv

Dementia and Cognitive Impairment ResearchMachine Learning in Healthcare

Cited by 5

Newer glucose‐lowering drugs and risk of suicidal ideation and behaviours: A network meta‐analysis of randomized outcome trials

Lu, Y., Tang, H., Kotecha, P., Cho, H., Donahoo, W. T., Bian, J., & Guo, J. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 3